Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?
Martin-Blondel
Guillaume
G
Cuzin
Lise
L
Delobel
Pierre
P
Cuvinciuc
Victor
V
Dumas
Hervé
H
Alvarez
Muriel
M
Massip
Patrice
P
Marchou
Bruno
B
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D003510:Cyclohexanes / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000188:drug therapy*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D000077592:Maraviroc; D014230:Triazoles / Q000627:therapeutic use*
D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D014230:Triazoles; D000077592:Maraviroc